From the Department of Family Medicine and Community Health, Research Division, Rutgers Robert Wood Johnson Medical School, New Brunswick, NJ (JRH, BFC, DOM, JH, RK, SVH); Rutgers Cancer Institute of New Jersey, New Brunswick, NJ (BFC, DOM, BB, SVH); School of Communication and Information, Rutgers University, New Brunswick, NJ (LM); NORC at the University of Chicago, Bethesda, MD (RK); Institute for Health, Health Care Policy and Aging Research, Rutgers University, New Brunswick, NJ (LM, BB, SVH); Department of Medicine, Division of General Internal Medicine, Rutgers Robert Wood Johnson Medical School, New Brunswick, NJ (BB).
J Am Board Fam Med. 2024 May-Jun;37(3):399-408. doi: 10.3122/jabfm.2023.230223R1.
Despite 2 decades of cancer survivorship research, policy, and advocacy, primary care in the United States has not fully integrated survivorship care into its generalist role. This manuscript describes innovative roles primary care physicians have adopted in survivorship care and how these roles emerged.
We conducted qualitative in-depth interviews with a snowball sample of 10 US primary care physician innovators in survivorship care. Interviews were recorded and professionally transcribed. Our team met weekly as interviews were completed to review transcripts and write summaries. We analyzed data using an immersion-crystallization process.
Innovators did not receive formal survivorship training but gained knowledge experientially and through self-guided education. All worked in academic primary care and/or cancer centers; context strongly influenced role operationalization. We delineated 4 major role-types along a spectrum, with primary care generalist orientations at one end and cancer generalist orientations at the other. Primary care generalists applied survivorship guidelines during regular visits ("GENERALISTS+") or focused on cancer treatment effects amid other comorbidities during blocked clinic time ("oncoGENERALISTS"). Cancer generalists focused on cancer-related sequalae during and after treatment; some provided continuity care to survivors ("ONCOGENERALISTS"), while others incorporated unmet primary care needs into survivorship consults ("ONCOgeneralists").
Primary care survivorship innovations are occurring in academic primary care and cancer centers settings in the US. To move beyond the work of individual innovators, systematic investments are needed to support adoption of such innovations. For wider diffusion of survivorship care into community primary care, additional strategies that include primary care survivorship education and workforce development are needed to facilitate risk-stratified and shared-care models.
尽管癌症生存研究、政策和宣传已经开展了 20 年,但美国的初级保健并未将生存护理完全纳入其全科医生角色。本文描述了初级保健医生在生存护理中采用的创新角色,以及这些角色是如何出现的。
我们对 10 名美国初级保健医生生存护理创新者进行了深入的定性访谈,采用了雪球抽样法。访谈进行了录音并由专业人员进行了转录。我们的团队在访谈完成后每周开会,以审查抄本并撰写总结。我们使用沉浸式结晶过程进行数据分析。
创新者没有接受过正式的生存培训,但通过经验和自我指导的教育获得了知识。所有人都在学术性初级保健和/或癌症中心工作;背景强烈影响角色的实施。我们沿着一个谱勾勒出 4 种主要的角色类型,一端是初级保健通才的取向,另一端是癌症通才的取向。初级保健通才在常规就诊期间应用生存指南(“通才+”),或者在专门的诊所时间内专注于癌症治疗效果和其他合并症(“肿瘤通才”)。癌症通才专注于治疗期间和之后的癌症相关后遗症;有些人为幸存者提供连续性护理(“ONCOGENERALISTS”),而另一些人则将未满足的初级保健需求纳入生存咨询(“ONCOgeneralists”)。
美国的学术性初级保健和癌症中心正在开展初级保健生存创新。为了超越个别创新者的工作,需要进行系统投资,以支持此类创新的采用。为了将生存护理更广泛地推广到社区初级保健中,需要采取包括初级保健生存教育和劳动力发展在内的其他策略,以促进风险分层和共享护理模式。